Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer

Immune checkpoint inhibitor therapies are used in the treatment of various cancers to stimulate an antitumor immune response. Checkpoint inhibitors, such as ipilimumab, pembrolizumab, and nivolumab, act by targeting inhibitory pathways and blocking the immune-evading effects of certain malignancies.1Shrimali R.K. Janik J.E. Abu-Eid R. Mkrtichyan M. Khleif S.N. Programmed death-1 & its ligands: promising targets for cancer...